Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.
Rossey, I., Gilman, M.S., Kabeche, S.C., Sedeyn, K., Wrapp, D., Kanekiyo, M., Chen, M., Mas, V., Spitaels, J., Melero, J.A., Graham, B.S., Schepens, B., McLellan, J.S., Saelens, X.(2017) Nat Commun 8: 14158-14158
- PubMed: 28194013 
- DOI: 10.1038/ncomms14158
- Primary Citation of Related Structures:  
5TOJ, 5TOK, 5TP3 - PubMed Abstract: 
Human respiratory syncytial virus (RSV) is the main cause of lower respiratory tract infections in young children. The RSV fusion protein (F) is highly conserved and is the only viral membrane protein that is essential for infection. The prefusion conformation of RSV F is considered the most relevant target for antiviral strategies because it is the fusion-competent form of the protein and the primary target of neutralizing activity present in human serum ...